INTERCEPT PHARMACEUTICALS, INC. Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in INTERCEPT PHARMACEUTICALS, INC. for February 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 4,327 | 45,001 | 4,326 | |
| Feb 18 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 368.90 | 500 | 184,451 | 7,218 | 7.7 K to 7.2 K (-6.48 %) |
| Feb 18 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 368.02 | 2,400 | 883,246 | 7,718 | 10.1 K to 7.7 K (-23.72 %) |
| Feb 18 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 366.91 | 1,240 | 454,972 | 10,118 | 11.4 K to 10.1 K (-10.92 %) |
| Feb 18 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 365.37 | 1,632 | 596,279 | 11,358 | 13 K to 11.4 K (-12.56 %) |
| Feb 18 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 4,327 | 45,001 | 12,990 | 8.7 K to 13 K (+49.95 %) |
| Feb 14 2014 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Option Exercise | M | 8.67 | 3,461 | 29,995 | 0 | |
| Feb 14 2014 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Option Exercise | M | 8.67 | 3,461 | 29,995 | 0 | |
| Feb 14 2014 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Sell | S | 367.51 | 324 | 119,073 | 1,655 | 2 K to 1.7 K (-16.37 %) |
| Feb 14 2014 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Sell | S | 383.00 | 922 | 353,126 | 1,979 | 2.9 K to 2 K (-31.78 %) |
| Feb 14 2014 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Sell | S | 382.00 | 500 | 191,000 | 2,901 | 3.4 K to 2.9 K (-14.70 %) |
| Feb 14 2014 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Sell | S | 381.00 | 500 | 190,500 | 3,401 | 3.9 K to 3.4 K (-12.82 %) |
| Feb 14 2014 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Sell | S | 379.79 | 136 | 51,652 | 3,901 | 4 K to 3.9 K (-3.37 %) |
| Feb 14 2014 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Sell | S | 378.66 | 864 | 327,166 | 4,037 | 4.9 K to 4 K (-17.63 %) |
| Feb 14 2014 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Sell | S | 375.00 | 1,000 | 375,000 | 4,901 | 5.9 K to 4.9 K (-16.95 %) |
| Feb 14 2014 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Sell | S | 373.00 | 500 | 186,500 | 5,901 | 6.4 K to 5.9 K (-7.81 %) |
| Feb 14 2014 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Sell | S | 372.00 | 500 | 186,000 | 6,401 | 6.9 K to 6.4 K (-7.25 %) |
| Feb 14 2014 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Sell | S | 370.00 | 1,500 | 555,000 | 6,901 | 8.4 K to 6.9 K (-17.86 %) |
| Feb 14 2014 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Sell | S | 368.17 | 500 | 184,086 | 8,401 | 8.9 K to 8.4 K (-5.62 %) |
| Feb 14 2014 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Buy | M | 8.67 | 3,461 | 29,995 | 8,901 | 5.4 K to 8.9 K (+63.62 %) |
| Feb 14 2014 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Buy | M | 8.67 | 3,461 | 29,995 | 5,440 | 2 K to 5.4 K (+174.89 %) |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Option Exercise | M | 0.00 | 324 | 0 | 649 | |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 385.04 | 52 | 20,022 | 2,282 | 2.3 K to 2.3 K (-2.23 %) |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 385.00 | 1 | 385 | 2,334 | 2.3 K to 2.3 K (-0.04 %) |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 384.77 | 1 | 385 | 2,335 | 2.3 K to 2.3 K (-0.04 %) |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 384.33 | 7 | 2,690 | 2,336 | 2.3 K to 2.3 K (-0.30 %) |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 374.09 | 1 | 374 | 2,343 | 2.3 K to 2.3 K (-0.04 %) |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 373.34 | 100 | 37,334 | 2,344 | 2.4 K to 2.3 K (-4.09 %) |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Buy | M | 0.00 | 324 | 0 | 2,444 | 2.1 K to 2.4 K (+15.28 %) |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | TALLARIGO LORENZO | Director | Option Exercise | M | 0.00 | 368 | 0 | 735 | |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | TALLARIGO LORENZO | Director | Sell | S | 354.52 | 368 | 130,463 | 1,640 | 2 K to 1.6 K (-18.33 %) |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | TALLARIGO LORENZO | Director | Buy | M | 0.00 | 368 | 0 | 2,008 | 1.6 K to 2 K (+22.44 %) |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Option Exercise | M | 0.00 | 324 | 0 | 649 | |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Buy | M | 0.00 | 324 | 0 | 2,304 | 2 K to 2.3 K (+16.36 %) |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Option Exercise | M | 0.00 | 324 | 0 | 649 | |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Buy | M | 0.00 | 324 | 0 | 1,979 | 1.7 K to 2 K (+19.58 %) |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Option Exercise | M | 10.40 | 2,000 | 20,800 | 6,000 | |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Sell | S | 310.04 | 500 | 155,020 | 6,392 | 6.9 K to 6.4 K (-7.25 %) |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Sell | S | 307.00 | 500 | 153,500 | 6,892 | 7.4 K to 6.9 K (-6.76 %) |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Sell | S | 301.78 | 1,000 | 301,780 | 7,392 | 8.4 K to 7.4 K (-11.92 %) |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Buy | M | 10.40 | 2,000 | 20,800 | 8,392 | 6.4 K to 8.4 K (+31.29 %) |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Option Exercise | M | 0.00 | 368 | 0 | 735 | |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Buy | M | 0.00 | 368 | 0 | 2,937 | 2.6 K to 2.9 K (+14.32 %) |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | M | 0.00 | 324 | 0 | 649 | |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Buy | M | 0.00 | 324 | 0 | 1,735,908 | 1.7 M to 1.7 M (+0.02 %) |